Tectorigenin ablates the inflammation-induced epithelial-mesenchymal transition in a co-culture model of human lung carcinoma.

CONCLUSION: These results clearly demonstrate the therapeutic potential of tectorigenin to prevent lung cancer elicited inflammatory and pro-metastatic response in monocytes and warrants further investigations to elucidate its mechanism of action.
PMID: 25712668 [PubMed - in process]

Source: Pharmacological Reports - February 26, 2015 Category: Drugs & Pharmacology Authors: Amin A, Mokhdomi TA, Bukhari S, Wani SH, Wafai AH, Lone GN, Qadri A, Qadri RA Tags: Pharmacol Rep Source Type: research